The Asia-Pacific region is close to eliminating malaria, but to “finish the job” there must be a focus on the most vulnerable communities, said Sarthak Das, CEO at APLMA.
Bhutan and East Timor were on the path to malaria elimination when the COVID-19 pandemic struck in 2020, disrupting their response. As the two countries adjust their timelines and set their sights to eliminate malaria by 2025, experts identify critical actions to get them back on track.
World Malaria Day 2022: Let’s focus on gender within malaria programming to provide equitable healthcare access to all. A new paper published by The Lancet Regional Health - Western Pacific explores how.
Ahead of World Malaria Day, a new paper published by The Lancet Regional Health-Western Pacific highlights key lessons drawn from Bhutan and Timor-Leste’s sustained malaria elimination efforts since their re-commitment to the World Health Organizations (WHO) E-2025 initiative last year. It details the approaches adapted by both countries to maintain the spotlight on malaria whilst preventing large COVID-19 outbreaks, as well as policies adopted to eliminate malaria by 2025.
As the Asia Pacific region continues to adapt to the evolving COVID-19 pandemic and the new global health landscape, countries in the region have shown unwavering resilience to accelerate progress in the fight against one of our oldest and deadliest diseases. This year’s APLMA Leaders’ Dashboard, which tracks progress towards malaria elimination reveals notable policy reforms and milestones, even amidst the challenges of the pandemic.
The Asia Pacific Leaders Malaria Alliance and Asia Pacific Malaria Elimination Network Welcome Single-dose Treatment ...
The Asia Pacific Leaders Malaria Alliance (APLMA) and Asia Pacific Malaria Elimination Network (APMEN) welcomes the recently approved (14 March 2022) use of single-dose tafenoquine by the Australian Therapeutic Goods Administration (TGA) for the prevention of relapsing Plasmodium vivax (P. vivax) malaria in children aged 2 years and above.